P1.01-40 EGFR ctDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease

MLA

Pender, A., et al. “P1.01-40 EGFR CtDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease.” Journal of Thoracic Oncology, vol. 14, no. 10, Number 10 Supplement 1, Oct. 2019, p. S373. EBSCOhost, https://doi.org/10.1016/j.jtho.2019.08.755.

APA

Pender, A., Hughesman, C., Law, E., Kristanti, A., Mcneil, K., Tucker, T., Bosdet, I., Young, S., Laskin, J., Karsan, A., Yip, S., & Ho, C. (2019). P1.01-40 EGFR ctDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease. Journal of Thoracic Oncology, 14(10, Number 10 Supplement 1), S373. https://doi.org/10.1016/j.jtho.2019.08.755

Chicago

Pender, A., C. Hughesman, E. Law, A. Kristanti, K. Mcneil, T. Tucker, I. Bosdet, et al. 2019. “P1.01-40 EGFR CtDNA Detection: The Impact of Site of Progression and Burden of Progressive Disease.” Journal of Thoracic Oncology 14 (10, Number 10 Supplement 1): S373. doi:10.1016/j.jtho.2019.08.755.